1st Quarter - Termination

THE GORLIN GROUP for AMERICAN BIOINDUSTRY ALLIANCE

Period 1st Quarter 2008 Filed Apr 11, 2008 Signed by Jacques J. Gorlin, President

Official filing
Firm
THE GORLIN GROUP
Client
AMERICAN BIOINDUSTRY ALLIANCE
Income
$20,000
Expenses
—
Terminated
Mar 25, 2008

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Encouraged the Congress and Executive Branch to oppose any attempts by foreign governments to negotiate new international agreements or to amend existing intellectual property agreements in the WTO and WIPO to weaken patent protection for biotechnology inventions. Encouraged the Congress and the Executive Branch to oppose the inclusion of genetic source disclosure requirements for the patenting of biotechnology inventions in any ABS regime negotiated in the CBD.

LobbyistCovered position, as disclosed
JACQUES J GORLIN —

Contacted: SENATE; Commerce, Dept of (DOC); State, Dept of (DOS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.